A new study by the WHO Regional Office for Europe and European Centre for Disease Prevention and Control (ECDC) published in Eurosurveillance estimates that 470,000 lives have been saved among those aged 60 years and over since the start of COVID-19 vaccination roll-out in 33 countries across the WHO European Region.
Europe is at a critical juncture in its fight against COVID-19. Many countries are currently relaxing restrictions, some against a backdrop of increasing numbers of cases and with new variants emerging, while still rolling out nationwide vaccination programmes.
This document outlines operational considerations for how to support the continuity of national influenza surveillance systems and public health laboratories for the epidemiological and virological surveillance for influenza in the 2020–2021 season during the ongoing COVID-19 pandemic.
ECDC has joined forces with EU-OSHA, the EU agency for occupational safety and health, to explore the use of rapid antigen tests for SARS-CoV-2, the virus that causes COVID-19, in the workplace.
The aim of this page is to provide a living, continuously updated overview on the evidence by specific vaccine product, age groups and SARS-CoV-2 variants.
The latest data from the European Centre for Disease Prevention and Control (ECDC) show a decrease in the total antibiotic consumption in humans by more than 15% between 2019 and 2020.
Displaced people from Ukraine hosted in reception centres should be offered free access to SARS-CoV-2 testing and vaccination for COVID-19. Additionally, protective measures are recommended by ECDC in the report Guidance for the prevention and control of COVID-19 in temporary reception centres in the context of the displacement of people from Ukraine, published on 18 March.